atenolol and disopyramide

atenolol has been researched along with disopyramide in 36 studies

Research

Studies (36)

Timeframe	Studies, this research(%)	All Research%
pre-1990	10 (27.78)	18.7374
1990's	8 (22.22)	18.2507
2000's	11 (30.56)	29.6817
2010's	6 (16.67)	24.3611
2020's	1 (2.78)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Lombardo, F; Obach, RS; Waters, NJ	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Esaki, T; Kawashima, H; Komura, H; Kuroda, M; Mizuguchi, K; Natsume-Kitatani, Y; Ohashi, R; Watanabe, R	1
Breithardt, G; Jochum, E; Kuhn, H; Seipel, L	1
Elliott, L; Grubb, BP; Hahn, H; Madu, E; Samoil, D; Temesy-Armos, P; Wolfe, D	1
Enquist, M; Hermansson, J	1
Angelo, HR; Bonde, J; Kampmann, JP; Pedersen, LE; Svendsen, TL; Trap-Jensen, J	1
Angelo, HR; Bonde, J; Bødtker, S; Kampmann, JP; Svendsen, TL	1
Wilcox, RG	1
Ahokas, JT; Davies, C; Ravenscroft, PJ	1
Bracchetti, D; Capucci, A; Catena, G; Lamberti, C; Magnani, B; Marchesini, B; Naccarella, F	1
Jewitt, DE	1
Van Durme, JP	1
Walden, RJ	1
Calkins, H; Morady, F; Seifert, M	1
Bou-Holaigah, I; Calkins, H; Kan, JS; Rowe, PC	1
Arita, M; Hara, M; Inoue, T; Ito, M; Maeda, T; Nakagawa, M; Saikawa, T; Shimoyama, N; Takaki, R; Yonemochi, H	1
Camm, AJ; Guo, X; Hnatkova, K; Malik, M; Murgatroyd, FD	1
Camm, AJ; Gallagher, MM; Guo, X; Hnatkova, K; Malik, M; Murgatroyd, FD; Waktare, JE	1
Camm, AJ; Guo, X; Hnatkova, K; Malik, M; Murgatroyd, FD; Waktare, JE	1
Dohmoto, H; Hashimoto, K; Sugiyama, A; Takahara, A; Yoshimoto, R	1
Date, H; Emori, T; Kajiya, M; Matsubara, H; Miyaji, K; Morita, H; Nakamura, K; Ohe, T; Tani, Y	1
Bando, T; Chen, F; Fujinaga, T; Hanaoka, N; Hasegawa, S; Sakai, H; Shoji, T	1
Elliott, P; Morgagni, R; Pasquale, F; Tomé-Esteban, MT	1

Reviews

2 review(s) available for atenolol and disopyramide

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Hemodynamic effects of newer antiarrhythmic drugs. American heart journal, 1980, Volume: 100, Issue:6 Pt 2 Topics: Acebutolol; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Atenolol; Benzeneacetamides; Disopyramide; Dogs; Hemodynamics; Humans; Mexiletine; Piperidines; Tocainide; Verapamil	1980

Trials

9 trial(s) available for atenolol and disopyramide

Article	Year
Anti-dysrhythmic treatment in acute myocardial infarction. Lancet (London, England), 1979, Jan-27, Volume: 1, Issue:8109 Topics: Acute Disease; Administration, Oral; Atenolol; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Humans; Injections, Intravenous; Lidocaine; Myocardial Infarction; Oxprenolol; Propranolol; Ventricular Fibrillation	1979
[The effect of some antiarrhythmic drugs on systolic time intervals in normal subjects (author's transl)]. Zeitschrift fur Kardiologie, 1978, Volume: 67, Issue:10 Topics: Adult; Ajmaline; Anti-Arrhythmia Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Disopyramide; Humans; Myocardial Contraction; Propiophenones; Propranolol; Quinidine; Systole; Time Factors	1978
Haemodynamic effects and kinetics of concomitant intravenous disopyramide and atenolol in patients with ischaemic heart disease. European journal of clinical pharmacology, 1986, Volume: 30, Issue:2 Topics: Aged; Atenolol; Coronary Disease; Disopyramide; Drug Therapy, Combination; Female; Heart Rate; Hemodynamics; Humans; Kinetics; Male; Middle Aged; Stroke Volume	1986
Acute intervention studies in patients with myocardial infarction using atenolol, propranolol, oxprenolol and disopyramide phosphate. Acta medica Scandinavica. Supplementum, 1981, Volume: 651 Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Oxprenolol; Propranolol; Pyridines	1981
[Comparison of disopyramide and atenolol in the therapy of stabilized ventricular extrasystole in patients with mitral valve prolapse]. Giornale italiano di cardiologia, 1981, Volume: 11, Issue:4 Topics: Adult; Atenolol; Cardiac Complexes, Premature; Disopyramide; Female; Heart Ventricles; Humans; Male; Middle Aged; Mitral Valve Prolapse; Pyridines	1981
Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias. Acta cardiologica. Supplementum, 1980, Issue:25 Topics: Arrhythmias, Cardiac; Atenolol; Chronic Disease; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Electrocardiography; Exercise Test; Heart Ventricles; Humans; Mexiletine; Propylamines	1980
Graphical representation of complex data--diurnal patterns of initiations of atrial fibrillation episodes. Pacing and clinical electrophysiology : PACE, 1997, Volume: 20, Issue:11 Topics: Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Circadian Rhythm; Computer Graphics; Cross-Over Studies; Digoxin; Disopyramide; Double-Blind Method; Electrocardiography, Ambulatory; Female; Humans; Male; Middle Aged; Probability	1997
Evolution of changes in the ventricular rhythm during paroxysmal atrial fibrillation. Pacing and clinical electrophysiology : PACE, 1998, Volume: 21, Issue:11 Pt 2 Topics: Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Cross-Over Studies; Digoxin; Disopyramide; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Middle Aged; Time Factors	1998
Age and gender influences on rate and duration of paroxysmal atrial fibrillation. Pacing and clinical electrophysiology : PACE, 1998, Volume: 21, Issue:11 Pt 2 Topics: Age Factors; Aged; Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Cross-Over Studies; Digoxin; Disopyramide; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Middle Aged; Sex Factors; Signal Processing, Computer-Assisted; Time Factors	1998

Other Studies

25 other study(ies) available for atenolol and disopyramide

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Development of an Journal of medicinal chemistry, 2021, 03-11, Volume: 64, Issue:5 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Cell Line; Computer Simulation; Endothelial Cells; Gene Knockout Techniques; Humans; Organic Chemicals; Rats, Transgenic	2021
Recurrent unexplained syncope in the elderly: the use of head-upright tilt table testing in evaluation and management. Journal of the American Geriatrics Society, 1992, Volume: 40, Issue:11 Topics: Aged; Aged, 80 and over; Atenolol; Beds; Blood Pressure; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Female; Head; Humans; Isoproterenol; Male; Monitoring, Physiologic; Posture; Prospective Studies; Recurrence; Scopolamine; Syncope	1992
Separation and quantitation of (R)- and (S)-atenolol in human plasma and urine using an alpha 1-AGP column. Chirality, 1989, Volume: 1, Issue:3 Topics: Atenolol; Chromatography; Chromatography, High Pressure Liquid; Disopyramide; Humans; Male; Orosomucoid; Spectrometry, Fluorescence; Stereoisomerism	1989
Atenolol inhibits the elimination of disopyramide. European journal of clinical pharmacology, 1985, Volume: 28, Issue:1 Topics: Adult; Aged; Atenolol; Coronary Disease; Dealkylation; Disopyramide; Female; Half-Life; Humans; Kinetics; Male	1985
Comparison of beta-adrenoceptor antagonists as modulators of drug metabolism: effect of lipophilicity on microsomal phase I and II reactions. British journal of clinical pharmacology, 1984, Volume: 17 Suppl 1 Topics: 7-Alkoxycoumarin O-Dealkylase; Adrenergic beta-Antagonists; Animals; Atenolol; Chemical Phenomena; Chemistry, Physical; Cytochrome P-450 CYP1A1; Disopyramide; In Vitro Techniques; Microsomes, Liver; Oxidoreductases; Oxygenases; Pharmaceutical Preparations; Propranolol; Rats; Solubility	1984
Is neurally mediated hypotension an unrecognised cause of chronic fatigue? Lancet (London, England), 1995, Apr-29, Volume: 345, Issue:8957 Topics: Atenolol; Disopyramide; Fatigue Syndrome, Chronic; Humans; Hypotension; Tilt-Table Test	1995
Clinical presentation and long-term follow-up of athletes with exercise-induced vasodepressor syncope. American heart journal, 1995, Volume: 129, Issue:6 Topics: Adolescent; Adult; Age of Onset; Atenolol; Bradycardia; Disopyramide; Drug Combinations; Exercise; Exercise Test; Female; Follow-Up Studies; Humans; Hypotension, Orthostatic; Male; Middle Aged; Monitoring, Physiologic; Recurrence; Sports; Syncope; Tilt-Table Test	1995
Is neurally mediated hypotension an unrecognised cause of chronic fatigue? Lancet (London, England), 1995, Mar-11, Volume: 345, Issue:8950 Topics: Adolescent; Atenolol; Autonomic Nervous System Diseases; Blood Pressure; Child; Disopyramide; Fatigue Syndrome, Chronic; Female; Humans; Hypotension; Male; Posture; Syncope; Tilt-Table Test	1995
Suppression of ventricular premature contractions continues after the washout of antiarrhythmic drugs. Japanese circulation journal, 1993, Volume: 57, Issue:1 Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Disopyramide; Electrocardiography, Ambulatory; Female; Humans; Male; Mexiletine; Middle Aged	1993
Cardiovascular action of a cardioselective Ca(2+)channel blocker AH-1058 in conscious dogs assessed by telemetry. European journal of pharmacology, 2001, Feb-09, Volume: 413, Issue:1 Topics: Animals; Atenolol; Blood Pressure; Bridged Bicyclo Compounds; Calcium Channel Blockers; Cardiovascular System; Consciousness; Disopyramide; Dogs; Heart Rate; Hemodynamics; Male; Piperidines; Substrate Specificity; Telemetry; Ventricular Pressure; Verapamil	2001
Failure of disopyramide to improve right ventricular outflow tract obstruction after living-donor lobar lung transplantation. Circulation journal : official journal of the Japanese Circulation Society, 2004, Volume: 68, Issue:11 Topics: Adult; Anti-Arrhythmia Agents; Atenolol; Cardiac Catheterization; Disopyramide; Echocardiography; Female; Heart; Hemodynamics; Humans; Living Donors; Lung Transplantation; Retreatment; Treatment Failure; Ventricular Outflow Obstruction	2004
Right ventricular outflow tract obstruction after bilateral lung transplantation. The Thoracic and cardiovascular surgeon, 2009, Volume: 57, Issue:1 Topics: Adult; Atenolol; Cardiac Surgical Procedures; Cardiovascular Agents; Disopyramide; Drug Therapy, Combination; Female; Heart Septal Defects, Atrial; Hemodynamics; Humans; Hypertension, Pulmonary; Lung Transplantation; Radiography; Treatment Outcome; Ventricular Outflow Obstruction	2009
Provokable left ventricular outflow tract obstruction in a patient without hypertrophy. Nature reviews. Cardiology, 2009, Volume: 6, Issue:4 Topics: Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Cardiac Pacing, Artificial; Diagnostic Imaging; Disopyramide; Drug Administration Schedule; Drug Therapy, Combination; Dyspnea; Heart Function Tests; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Risk Factors; Treatment Outcome; Ventricular Outflow Obstruction	2009